Mount Sinai School of Medicine

The Emergency Medicine Residency at The Mount Sinai Hospital is an extraordinary, well-balanced clinical training that offers a complete training program for tomorrow’s leaders in Emergency Medicine.

Through training at both of Mount Sinai's complementary, high-volume clinical sites our residents graduate prepared to work anywhere. We offer rich opportunities in all areas of Emergency Medicine, along with generous elective time and mentoring from our dedicated faculty, allowing residents to participate in cutting-edge projects.

Our Senior Specialty Tracks, or "mini-fellowships," allow you to develop extra skills and knowledge in an area of interest, setting the foundation for a multidimensional career.

As a result, our graduates consistently obtain sought-after academic, private, and fellowship positions wherever they choose to go after training, including the nation's tightest job markets.

An estimated 6.5 million Americans suffer from heart failure, a broad term that can encompass a range of patients. Acute decompensated heart failure may be the first presentation of a heart condition,
It's been an exciting spring for advocacy. We stay alert so that every time a decision that affects EM residents' lives is being made, the EM residents' voice on the matter is heard loud and clear.
The use of exogenous steroids in septic shock is a controversial issue with inconsistent data on mortality to date. Several studies examine sepsis treatment. What does the evidence show?
EMRA helps make you the best doctor you can be, the best leader you can be, and helps make EM the best specialty it can be, through our unrivaled advocacy.
Omar Maniya, a second-year resident at The Mount Sinai Hospital in New York City, began his tenure as EMRA President in October. With an MBA from Harvard University, experience as the youngest Trustee
As EMRA prepared for its 45th anniversary in the year ahead, we honor our roots and look forward to building on those accomplishments.
A federal lawsuit has been filed to halt the dangerous but growing practice of retroactively denying insurance claims if a condition is later deemed not to have been an emergency.
Ischemic stroke is one of the most common causes of death and devastating permanent disability worldwide. Two new trials - DAWN and DEFUSE 3 - suggest endovascular therapy could benefit patients prese
Our March 2018 Critical Care Alert compares early use of APRV and LTV in ARDS patients in ICU.
NULL
EMRA Wellness: New Year, New You! The new year is upon us, and that means many of us will be setting goals for the new year. That's great! Goals are an important part of wellness. Whether professiona